MTRR Gene Spina bifida folate sensitive Genetic Test
Components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test type: Dysmorphology
- Doctor: Pediatrics
- Test Department: Genetics
Pre Test Information:
Clinical History of Patient who is going for MTRR Gene Spina bifida folate sensitive NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MTRR Gene Spina bifida folate sensitive NGS Genetic DNA Test gene MTRR.
Test Details:
The MTRR gene is involved in the metabolism of folate, a B-vitamin that is important for DNA synthesis and repair. Spina bifida is a birth defect that affects the development of the spine and spinal cord. Certain variations or mutations in the MTRR gene can increase the risk of spina bifida and affect how the body processes folate.
NGS (Next-Generation Sequencing) is a genetic testing method that allows for the simultaneous analysis of multiple genes, including the MTRR gene. This technology can detect genetic variations or mutations in the MTRR gene associated with spina bifida and folate sensitivity.
The MTRR gene spina bifida folate sensitive NGS genetic test involves collecting a sample of DNA, usually through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any genetic variations or mutations in the MTRR gene.
The results of the test can provide information about an individual’s risk of developing spina bifida and their sensitivity to folate. This information can guide medical management and treatment decisions, such as the use of folate supplements during pregnancy to prevent spina bifida in at-risk individuals.
It is important to note that genetic testing for spina bifida and folate sensitivity is typically not performed as a standalone diagnostic test. It is usually used in combination with other clinical evaluations and tests to provide a more comprehensive understanding of an individual’s risk and potential treatment options.
Genetic counseling is also often recommended before and after genetic testing to help individuals understand the implications of the results and make informed decisions.
Test Name | MTRR Gene Spina bifida folate sensitive Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Dysmorphology |
Doctor | Pediatrics |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for MTRR Gene Spina bifida folate sensitive NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MTRR Gene Spina bifida folate sensitive NGS Genetic DNA Test gene MTRR |
Test Details |
The MTRR gene is involved in the metabolism of folate, a B-vitamin that is important for DNA synthesis and repair. Spina bifida is a birth defect that affects the development of the spine and spinal cord. It has been found that certain variations or mutations in the MTRR gene can increase the risk of spina bifida, and these variations may also affect how the body processes folate. NGS (Next-Generation Sequencing) is a genetic testing method that allows for the simultaneous analysis of multiple genes, including the MTRR gene. This technology can detect various genetic variations or mutations in the MTRR gene that may be associated with spina bifida and folate sensitivity. The MTRR gene spina bifida folate sensitive NGS genetic test involves collecting a sample of DNA, usually through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any genetic variations or mutations in the MTRR gene. The results of the test can provide information about an individual’s risk of developing spina bifida and their sensitivity to folate. This information can be useful for guiding medical management and treatment decisions, such as the use of folate supplements during pregnancy to prevent spina bifida in at-risk individuals. It is important to note that genetic testing for spina bifida and folate sensitivity is typically not performed as a standalone diagnostic test. It is usually used in combination with other clinical evaluations and tests to provide a more comprehensive understanding of an individual’s risk and potential treatment options. Genetic counseling is also often recommended before and after genetic testing to help individuals understand the implications of the results and make informed decisions. |